Sivri F, Şencan M, Öztürk ŞB, Maraşlı AS, İçen YK, Akgüllü Ç. Prognostic Value of Non-HDL Cholesterol in COVID-19 Pneumonia.
Arq Bras Cardiol 2023;
120:e20220671. [PMID:
37311127 PMCID:
PMC10263406 DOI:
10.36660/abc.20220671]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2022] [Revised: 02/05/2023] [Accepted: 04/05/2023] [Indexed: 06/15/2023] Open
Abstract
BACKGROUND
In addition to coronary artery disease, non-high-density lipoprotein(non-HDL-C) provides short and long-term predictive information for many chronic inflammatory diseases such as stroke, hemodialysis, post-renal transplant, non-alcoholic hepatosteatosis, and human immunodeficiency virus.
OBJECTIVES
This study examined the predictive value of non-HDL-C measured before SARS-CoV-2 for mortality in COVID-19 infection.
METHODS
This study retrospectively included 1435 patients diagnosed with COVID-19 and treated in the thoracic diseases ward in a single center between January 2020 and June 2022. All patients included in the study had clinical and radiological features and signs of COVID-19 pneumonia. The COVID-19 diagnosis of all patients was confirmed by a polymerase chain reaction studied from an oropharyngeal swab. Statistical significance was set at p < 0.05.
RESULTS
The study patients, including 1435 subjects, were divided into 712 patients in the non-surviving group and 723 in the surviving group. While there was no difference between the groups regarding gender, there was a statistically significant age difference. The non-surviving group was older. Age, lactate dehydrogenase(LDH), C reactive protein(CRP), triglycerides, D-dimer, and non-HDL-C were independent risk factors for mortality in regression analyses. In correlation analysis, age, CRP, and LDH were positively correlated with non-HDL-C. In the ROC analysis, sensitivity for non-HDL-C was 61.6%, and specificity was 89.2%.
CONCLUSION
We believe that the non-HDL-C level studied before COVID-19 infection can be used as a prognostic biomarker for the disease.
Collapse